Impact on Mexico of the U.S. 2026 Anti-Drug Strategy and the New Paradigm of Trade and Financial Compliance Tied to National Security

On May 4, 2026, the White House Office of National Drug Control Policy published the 2026 National Drug Control Strategy (“NDCS 2026”), setting out the U.S. government’s approach to, among other matters, synthetic drug trafficking, particularly fentanyl and methamphetamine. The strategy combines interdiction, intelligence, supply chain security, financial sanctions and international cooperation within a broader national security framework.

For companies operating in Mexico, the NDCS 2026 is relevant because it signals heightened expectations regarding traceability, due diligence and controls over supply chains and financial transactions with a U.S. nexus. The strategy does not replace obligations under Mexican law or, by itself, create generally applicable new obligations for companies in Mexico. It may, however, increase exposure to U.S. information requests, reviews, financial measures or enforcement actions where sufficient jurisdictional links exist.

The strategy identifies the land border with Mexico as the principal corridor for illicit drugs that, from the U.S. government’s perspective, pose the gravest threat to American lives. It also states that transnational criminal organizations operating in Mexico and designated as Foreign Terrorist Organizations (“FTOs”) participate in global networks spanning precursor chemical procurement, clandestine production and the distribution of synthetic drugs into the United States.

From a trade perspective, the NDCS 2026 develops Supply Chain Integrity principles focused on transparency, accountability, due diligence and enhanced data verification throughout supply chains. The strategy contemplates expanding participation in and data requirements associated with the Customs Trade Partnership Against Terrorism (“CTPAT”), a voluntary program administered by U.S. Customs and Border Protection, with particular attention to shipping, logistics, chemical, pharmaceutical, laboratory equipment and pill press manufacturing industries.

Against this backdrop, Mexican companies involved in international trade may face increased expectations regarding the traceability of customers, suppliers, goods, routes and supporting documentation, particularly when they form part of supply chains entering the United States.

The strategy also addresses the suspension of de minimis tariff treatment for shipments from all countries. This regime had allowed certain commercial shipments valued below USD $800 to enter the United States duty-free and with simplified customs processing. Its suspension increases the amount of information available to U.S. authorities and the level of review applied to these shipments, with potential implications for Mexican e-commerce companies and exporters.

A further important element is the financial dimension. The NDCS 2026 contemplates the use of financial intelligence, sanctions, investigations and special authorities to identify and restrict flows linked to transnational criminal organizations. The U.S. Department of the Treasury intends to use Bank Secrecy Act reporting, financial intelligence from international partners and special measures authorities to identify transactions and restrict access to the U.S. financial system in appropriate cases.

For Mexico, the strategy anticipates closer coordination in financial intelligence and anti-money laundering matters. Accordingly, banks, money transmitters, exchange houses, fintech companies, international trade operators and other participants in payment or cross-border structures may face increased scrutiny where risk indicators involving drug trafficking, money laundering or designated entities are present.

Sectors with potentially greater exposure include:

• Financial and payment services: banks, fintech companies, exchange houses, money transmitters and other entities processing cross-border transactions.

• Chemical and pharmaceutical industries: companies producing, storing, transporting or commercializing precursor chemicals or other inputs susceptible to diversion.

• Logistics and international trade: carriers, parcel delivery companies, port operators, customs brokers and other providers involved in the international movement of goods.

• Technology and telecommunications: platforms and providers that may become involved in investigations relating to digital marketplaces, communications or activities associated with designated organizations.

• Real estate: owners, landlords and operators of properties that may be used, directly or indirectly, for activities connected with organizations subject to U.S. measures.

From a practical standpoint, the significance of the NDCS 2026 for companies lies not only in identifying areas of increased scrutiny, but also in assessing whether their compliance programs allow them to demonstrate a reasonable understanding of their counterparties, supply chains and financial flows.

Companies may wish to review the effectiveness and documentation of their anti-money laundering and counter-terrorist financing programs; beneficial ownership identification processes; customer, supplier and intermediary due diligence; traceability of goods and routes; controls applicable to critical third parties; and procedures for identifying sanctioned counterparties or entities linked to designated organizations.

For companies in the chemical, pharmaceutical and logistics sectors, it may also be important to assess whether internal controls are consistent with supply chain integrity principles, including verification of suppliers, customers, goods, supporting documentation and transportation routes.

Legal, compliance, procurement, logistics, treasury and corporate security functions should also have clear procedures to identify red flags, document decisions and escalate transactions presenting heightened risk.

The NDCS 2026 does not, by itself, amend the Mexican legal framework applicable to companies. Its implementation may nevertheless increase compliance and cooperation expectations for businesses with U.S.-linked operations, customers, suppliers, financial institutions or supply chains. A preventive review of internal controls may help mitigate regulatory, financial, operational and reputational risks in an environment of increased cross-border scrutiny.

Von Wobeser y Sierra is available to assess the implications of the NDCS 2026 for operations in Mexico and to assist with reviews of compliance programs, anti-money laundering controls, supply chains and exposure to U.S. measures.